The company’s antibody therapy has been determined to be ineffective against the omicron variant that now dominates Covid-19 cases worldwide.
Subscribe to:
Post Comments (Atom)
< + > Military Intelligence Meets Pharma Strategy – Life Sciences Today Podcast Episode 66
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Tony Page, Senior...
No comments:
Post a Comment